Emparol-M Tablet 5 mg+500 mg is a combination oral anti-diabetic medication containing Empagliflozin (5 mg) and Metformin Hydrochloride (500 mg), formulated for the management of type 2 diabetes mellitus (T2DM) in adults. This dual-action tablet combines the benefits of two widely used anti-diabetic agents to provide enhanced glycemic control through complementary mechanisms.

• Empagliflozin, a SGLT2 (sodium-glucose co-transporter 2) inhibitor, works in the kidneys by reducing glucose reabsorption, thereby increasing urinary glucose excretion. This not only lowers blood sugar but also supports weight reduction and cardiovascular protection.

• Metformin Hydrochloride, a biguanide class medication, decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake, making it a cornerstone of type 2 diabetes management.

The combination of Empagliflozin and Metformin in Emparol-M provides comprehensive glycemic control, targeting both renal glucose excretion and hepatic glucose production. This makes it ideal for patients who require better blood sugar management than either drug alone.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Emparol-M Tablet 5 mg+500 mg is indicated for:

• Type 2 Diabetes Mellitus (T2DM): For adults who are inadequately controlled on diet and exercise alone

• Adjunct therapy: Can be combined with other anti-diabetic medications if further glycemic control is needed

• Fasting and postprandial glucose management: Helps maintain stable blood sugar levels throughout the day

• Weight and cardiovascular support: Empagliflozin promotes modest weight loss and may reduce the risk of cardiovascular complications in patients with diabetes

• Renal support considerations: Suitable for patients with adequate kidney function as part of long-term diabetes management

This formulation is particularly beneficial for adults who require effective dual-action therapy to achieve target blood glucose levels and reduce diabetes-related complications.

Dosage and Administration

• Adults: One tablet twice daily, preferably with meals, or as prescribed by a healthcare professional

• Swallow the tablet whole with water; do not crush, chew, or split

• Regular monitoring of blood glucose, HbA1c, kidney function, and metabolic parameters is recommended

• Maintain a balanced diet and regular physical activity to maximize the effects of therapy

• Dosage adjustments may be required for patients with renal impairment or other underlying medical conditions

Precautions

• Not recommended for patients with type 1 diabetes, severe renal impairment, or diabetic ketoacidosis

• Use caution in individuals with a history of lactic acidosis, liver disease, or dehydration

• Avoid use in patients with a history of urinary tract infections or genital infections

• Monitor for hypoglycemia when used with insulin or sulfonylureas

• Inform your healthcare provider of all medications and medical conditions before starting therapy

• Pregnant and breastfeeding women should consult a physician before use

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Emparol-M Tablet 5 mg+500 mg is generally well tolerated. Common side effects may include:

• Gastrointestinal disturbances such as nausea, vomiting, diarrhea, or bloating (from Metformin)

• Increased urination (from Empagliflozin)

• Urinary tract or genital infections

• Mild headache or dizziness

Rare but serious side effects may include:

• Lactic acidosis (severe Metformin-related complication)

• Ketoacidosis (from Empagliflozin)

• Severe dehydration or hypotension

• Hypoglycemia when combined with insulin or sulfonylureas

• Kidney impairment or electrolyte imbalance

Patients experiencing serious or persistent side effects should seek immediate medical attention.

Storage

Store in a cool, dry place below 30°C, protected from sunlight and moisture. Keep out of reach of children.

Emparol-M Tablet 5 mg+500 mg provides effective dual-action management of type 2 diabetes, combining renal glucose excretion with reduced hepatic glucose production. Its convenient twice-daily dosing supports better glycemic control, weight management, and cardiovascular protection, making it a reliable option for adult patients managing type 2 diabetes.